GLP1: otra herramienta en el tratamiento de la diabetes tipo 2 / Eficacy and safety of incretin therapy in type 2 diabetes

ABSTRACT

Type II diabetes is a disease characterized by insuline resistance and abnormalities of the B-cells, and it is associated with hyperglucosanemia, the increase of the production of hepatic glucose and with obesity. This article refers to a new therapeutic tool for the treatment of type II diabetes the incretin system. The efficacy and safety of incretin therapy for diabetes mellitus type II, is referred in the article. Furher studies are required to achieve a definitive evaluative conclusion about these therapeutic agents.